230 related articles for article (PubMed ID: 33913850)
21. Resolution of recalcitrant pyogenic granuloma with laser, corticosteroid, and timolol therapy.
Millsop JW; Trinh N; Winterfield L; Berrios R; Hutchens KA; Tung R
Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656264
[TBL] [Abstract][Full Text] [Related]
22. Topical timolol in dermatology: infantile haemangiomas and beyond.
Alzaid M; Al-Naseem A; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2022 May; 47(5):819-832. PubMed ID: 34798680
[TBL] [Abstract][Full Text] [Related]
23. Combination of ligation and timolol before surgical excision of pyogenic granuloma.
Baek YS; Kwon SH; Jeon J
J Am Acad Dermatol; 2018 Jun; 78(6):e141-e142. PubMed ID: 29307642
[No Abstract] [Full Text] [Related]
24. Pyogenic granulomas in childhood: New treatment modalities.
Patrizi A; Gurioli C; Dika E
Dermatol Ther; 2015; 28(5):332. PubMed ID: 25818498
[No Abstract] [Full Text] [Related]
25. RF - FTopical Timolol in Dermatology.
Lopez-Bernal T; Aranegui B
Actas Dermosifiliogr; 2023 Apr; 114(4):334-335. PubMed ID: 36126701
[No Abstract] [Full Text] [Related]
26. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Michaud JE; Friren B;
Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
[TBL] [Abstract][Full Text] [Related]
27. Treatment of a Large Nail-Bed Pyogenic Granuloma with Topical Timolol.
Frommer SA; Leathers KO
J Am Podiatr Med Assoc; 2023; 113(1):. PubMed ID: 36905620
[TBL] [Abstract][Full Text] [Related]
28. Pyogenic granuloma in ten children treated with topical imiquimod.
Tritton SM; Smith S; Wong LC; Zagarella S; Fischer G
Pediatr Dermatol; 2009; 26(3):269-72. PubMed ID: 19706086
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of topical propranolol 4% gel in the treatment of pyogenic granuloma in children.
Mashiah J; Hadj-Rabia S; Slodownik D; Harel A; Sprecher E; Kutz A
J Dermatol; 2019 Mar; 46(3):245-248. PubMed ID: 30593715
[TBL] [Abstract][Full Text] [Related]
30. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
[TBL] [Abstract][Full Text] [Related]
31. Letter to the editor regarding "Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomised, double-blind and placebo-controlled study".
Monteiro RC; Shetty P; Marne RB; Mysore V; Patil SR
Indian J Dermatol Venereol Leprol; 2023; 89(1):76. PubMed ID: 36461800
[No Abstract] [Full Text] [Related]
32. Clinical evaluation of a new formula of timolol maleate (WP-934 ophthalmic solution). WP-934 Study Group.
Yamamoto T; Kitazawa Y; Azuma I; Tsukahara S; Nakashima M
Jpn J Ophthalmol; 1997; 41(4):244-50. PubMed ID: 9304439
[TBL] [Abstract][Full Text] [Related]
33. Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study.
Yen CF; Hsu CK; Yang HS; Lee CN; Chi CC; Chung WH; Wang CL; Pang JS; Wang CW; Ko YS; Lu CW
Int J Dermatol; 2020 Mar; 59(3):326-332. PubMed ID: 31763692
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.
Nicolela MT; Buckley AR; Walman BE; Drance SM
Am J Ophthalmol; 1996 Dec; 122(6):784-9. PubMed ID: 8956632
[TBL] [Abstract][Full Text] [Related]
35. Effect of topical beta-blockers on tissue blood flow in the human optic nerve head.
Tamaki Y; Araie M; Tomita K; Nagahara M; Tomidokoro A
Curr Eye Res; 1997 Nov; 16(11):1102-10. PubMed ID: 9395769
[TBL] [Abstract][Full Text] [Related]
36. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
[TBL] [Abstract][Full Text] [Related]
37. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension.
Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
Arzneimittelforschung; 2006; 56(11):729-34. PubMed ID: 17220049
[TBL] [Abstract][Full Text] [Related]
38. Topical timolol for small hemangiomas of infancy.
Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
[TBL] [Abstract][Full Text] [Related]
39. Treatment of small superficial haemangioma with timolol 0.5% ophthalmic solution: a series of 20 cases.
Oranje AP; Janmohamed SR; Madern GC; de Laat PC
Dermatology; 2011; 223(4):330-4. PubMed ID: 22179543
[TBL] [Abstract][Full Text] [Related]
40. Pyogenic Granuloma of the Lip With Complete Resolution After Topical Propranolol.
Goetze AC; Sasaya EMK; Cerci FB; Tolkachjov SN; Werner B
J Drugs Dermatol; 2019 Oct; 18(10):1061-1062. PubMed ID: 31603637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
